Auxilart
Auxilart is a pharmaceutical process development company that accelerates R&D by replacing physical experiments with digital simulations. Their proprietary technology, developed over 10 years at the University of Tokyo, uses mechanistic models based on differential equations, unlike AI-driven approaches. This allows them to significantly reduce costs and development time, requiring only a fraction of the data typically needed. They address challenges in biopharmaceuticals, regenerative medicine, and small molecules, aiming to speed up the delivery of treatments to patients and improve manufacturing processes. Auxilart's mission is to leverage digital innovation to overcome development hurdles and enhance global health and well-being.
Auxilart
Auxilart is a pharmaceutical process development company that accelerates R&D by replacing physical experiments with digital simulations. Their proprietary technology, developed over 10 years at the University of Tokyo, uses mechanistic models based on differential equations, unlike AI-driven approaches. This allows them to significantly reduce costs and development time, requiring only a fraction of the data typically needed. They address challenges in biopharmaceuticals, regenerative medicine, and small molecules, aiming to speed up the delivery of treatments to patients and improve manufacturing processes. Auxilart's mission is to leverage digital innovation to overcome development hurdles and enhance global health and well-being.